The Biotech Growth Trust PLC (LON:BIOG - Get Free Report) shares passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of GBX 886.16 ($11.03) and traded as low as GBX 875 ($10.89). The Biotech Growth Trust shares last traded at GBX 881 ($10.97), with a volume of 164,870 shares trading hands.
The Biotech Growth Trust Price Performance
The company's 50 day simple moving average is GBX 886.16 and its two-hundred day simple moving average is GBX 971.53. The company has a debt-to-equity ratio of 13.03, a current ratio of 0.33 and a quick ratio of 0.00. The stock has a market capitalization of £284.67 million, a P/E ratio of 428.02 and a beta of 0.50.
The Biotech Growth Trust (LON:BIOG - Get Free Report) last issued its quarterly earnings results on Wednesday, November 27th. The company reported GBX 0.20 ($0.00) earnings per share (EPS) for the quarter. The Biotech Growth Trust had a net margin of 92.85% and a return on equity of 21.57%.
Insider Buying and Selling
In other news, insider Julie Tankard acquired 1,022 shares of the stock in a transaction that occurred on Wednesday, December 4th. The stock was acquired at an average price of GBX 972 ($12.10) per share, for a total transaction of £9,933.84 ($12,367.83). Also, insider Nicola Shepherd bought 1,000 shares of The Biotech Growth Trust stock in a transaction on Monday, January 13th. The shares were acquired at an average price of GBX 846 ($10.53) per share, for a total transaction of £8,460 ($10,532.87). Insiders bought a total of 6,222 shares of company stock worth $5,659,584 over the last three months. 0.71% of the stock is currently owned by company insiders.
The Biotech Growth Trust Company Profile
(
Get Free Report)
The Biotech Growth Trust seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis. Performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).
Read More
Before you consider The Biotech Growth Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Biotech Growth Trust wasn't on the list.
While The Biotech Growth Trust currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
